DEVELOPMENT OF REAGENTS FOR STEM CELL DIFFERENTIATION

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$749,999.00
Award Year:
1998
Program:
SBIR
Phase:
Phase II
Contract:
n/a
Agency Tracking Number:
29500
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Quality Biological, Inc.
7581 Lindbergh Drive, Gaithersburg, MD, 20879
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Ronald Brown
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
We will develop chemically defined reagents that support hematopoietic stem cell proliferation andSuch reagents would be valuable in hematological research especially for bone marrow transplantationex-vivo purging. Preliminary evidence indicates that it is feasible to replace the ill-defined and uwith defined chemicals. A hallmark in the progress of hematological research has been the developmenreagents. The serum-free reagents are a dramatic improvement over serum containing reagents but stilcomponents as BSA. Replacement of these ill-defined components would be of inestimable importance esdevelopment of U.S. pharmaceutical grade reagents. Typically these reagents have required the presenproducts, by-passing such components would eliminate the problems associated with blood procurementvolunteers (hepatitis, HIV, etc.) along with the time and material involved. The Phase II effort wildevelopment and optimization of chemically defined reagents for bone marrow expansion and their evalbone marrow transplantation, gene therapy and ex vivo purging.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government